ViCentra

ViCentra

Private
UtrechtHealthcare & Life Scienceshttps://hellokaleido.com/

Last Round

Series D

Extension

Jan 8, 2026

Total Funding Raised

$182.87M

Momentum Score

50 /100

Company Overview

ViCentra is a medical device company that develops and manufactures the Kaleido insulin patch pump system, a small and light wearable device designed for people with diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Precision Medicine, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

insulin pumppatch pumptype 1 diabeteshybrid closed-loop systemautomated insulin deliveryAID systeminsulin deliverydiabetes technologyrechargeable insulin pumpartificial pancreaswearable medical deviceCGM integrationdiatechmedical deviceHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViCentra Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ViCentra Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionJan 8, 2026
Series DSep 3, 2025
Series CDec 16, 2021
VC RoundJul 8, 2020
Series BJan 16, 2016

ViCentra Investors

Notable investors and investment history

InvestorRounds
Kreos CapitalVC Round
Venturing TechSeries D Extension
EQT Life SciencesSeries C, Series D, VC Round, Series B
Invest-NLSeries C, Series D, VC Round
ROM Utrecht RegionSeries D Extension
Partners in EquitySeries D, Series C
Inkef CapitalSeries C, Series D, Series B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Kaleido insulin pump now immediately available for new users.

  • Apr 15, 2026

    Monthly visitors increased 84% MoM.

ViCentra Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViCentra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViCentra's valuation, stock price, and market status.

Firmographic Details

HeadquartersUtrecht
Employee Range193
Year Founded2013
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.